StacksVerified U.S. regulatory reference

21 CFR §1317.40

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov
  1. (a)Manufacturers, distributors, reverse distributors, narcotic treatment programs, hospitals/clinics with an on-site pharmacy, and retail pharmacies that desire to be collectors shall modify their registration to obtain authorization to be a collector in accordance with § 1301.51 of this chapter. Authorization to be a collector is subject to renewal. If a registrant that is authorized to collect ceases activities as a collector, such registrant shall notify the Administration in accordance with § 1301.52(f) of this chapter.
  2. (b)Collection by registrants shall occur only at the following locations:
    1. (1)Those registered locations of manufacturers, distributors, reverse distributors, narcotic treatment programs, hospitals/clinics with an on-site pharmacy, and retail pharmacies that are authorized for collection; and
    2. (2)Long-term care facilities at which registered hospitals/clinics or retail pharmacies are authorized to maintain collection receptacles.
  3. (c)Collectors may conduct the following activities:
    1. (1)Receive and destroy mail-back packages pursuant to § 1317.70 at an authorized registered location that has an on-site method of destruction;
    2. (2)Install, manage, and maintain collection receptacles located at their authorized collection location(s) pursuant to §§ 1317.75 and 1317.80; and
    3. (3)Promptly dispose of sealed inner liners and their contents as provided for in § 1317.05(c)(2).